As of 2025-05-17, the Relative Valuation of Adverum Biotechnologies Inc (ADVM) is (66.35) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.12 USD, the upside of Adverum Biotechnologies Inc based on Relative Valuation is -3237.0%.
The range of the Relative Valuation is (40.67) - (84.18) USD.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| Trailing P/E multiples | 8.6x - 18.5x | 14.3x |
| Forward P/E multiples | 8.9x - 20.6x | 14.8x |
| Fair Price | (40.67) - (84.18) | (66.35) |
| Upside | -2023.2% - -4080.0% | -3237.0% |
| Date | P/E |